A report this week from NBC4 Washington flagged a nationwide recall of Clear Eyes eye drop products due to contamination concerns, pulling the widely distributed over-the-counter product from pharmacy shelves across the country, including throughout Washington state.
The recall was issued over contamination concerns identified in certain Clear Eyes formulations. The FDA maintains a publicly searchable recall database where affected lot numbers and product UPCs can be verified; Washington consumers who purchased Clear Eyes products recently are encouraged to cross-reference their purchases there. The Washington State Department of Health and the state's Pharmacy Quality Assurance Commission both serve as in-state channels through which recall notices are distributed to licensed pharmacies in cities including Seattle, Spokane, Tacoma, and Bellingham.
Clear Eyes, manufactured by Prestige Consumer Healthcare, is one of the most recognizable names in the OTC eye care market and is stocked in virtually every major pharmacy chain operating in Washington, including Bartell Drugs — a Pacific Northwest regional staple — as well as national chains like Walgreens, CVS, and Rite Aid. The scale of the distribution network means affected units were likely present in a broad cross-section of the state's retail pharmacies before the recall was initiated.
For readers who track household medical supply readiness, this recall is a useful reminder of a pattern that has recurred with OTC pharmaceutical products: contamination events — whether microbial, particulate, or chemical — can simultaneously remove a product from circulation at every retail point in a region. Washington's Puget Sound corridor and its more rural eastern counties face the same supply disruption at the same moment, with no geographic buffer. Readers interested in how preppers and emergency planners think about pharmaceutical shelf stock and recall vulnerability can find relevant context in our eye drop and OTC medicine storage review. The state's existing emergency management infrastructure, coordinated through the Washington State Emergency Management Division, does not typically backstop OTC product recalls, meaning the gap between recall and restocking falls entirely on commercial supply chains.
